Can the ravages of uncontrolled systemic inflammatory response be regulated by amphibian antimicrobial peptides?
Appavu
Samuel K
SK
D029845:Amphibian Proteins / Q000494:pharmacology*; D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology*; D018988:Bacterial Translocation / Q000187:drug effects*; D001652:Bile Ducts / Q000601:surgery; D004195:Disease Models, Animal; D004731:Endotoxins / Q000097:blood; D041781:Jaundice, Obstructive / Q000382:microbiology*; D054806:Magainins; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D010878:Piperacillin / Q000494:pharmacology; D051381:Rats; D000078142:Tazobactam; D029867:Xenopus Proteins / Q000494:pharmacology*
D029845:Amphibian Proteins; D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D004731:Endotoxins; D054806:Magainins; D010455:Peptides; D029867:Xenopus Proteins; C121472:uperin 3.6 peptide, Uperoleia mjobergii; C053301:magainin 2 peptide, Xenopus; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin